Brenus Pharma
Entry
2024
Hold
2yr
Status
Active
Who owns Brenus Pharma?
Brenus Pharma is a French Biotech company, currently owned by UI Investissement since 2024 and ANGELOR.
Hand-verified · updated 2026-04-21
Open JSON · CC-BYOwnership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
UI InvestissementActive
2024 · present(2yr) · UI Investissement · 2005 · Growth
ANGELORActive
2024 · present(2yr) · Angelor · 2014 · VC
More from Angelor
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Brenus Pharma?
Brenus Pharma is currently owned by UI Investissement and ANGELOR, through Angelor, since 2024.
When did UI Investissement and 1 other acquire Brenus Pharma?
UI Investissement and 1 other acquired Brenus Pharma in 2024.
Who has owned Brenus Pharma over time?
Brenus Pharma has been through 2 private-equity ownership periods: UI Investissement · via UI Investissement · since 2024; ANGELOR · via Angelor · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue